These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31905329)

  • 1. Flavivirus Immunity in Disease Control and Viral Pathogenesis.
    Wang T
    Viral Immunol; 2020; 33(1):1-2. PubMed ID: 31905329
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in Flavivirus research.
    Woodland DL
    Viral Immunol; 2010 Jun; 23(3):233-4. PubMed ID: 20565287
    [No Abstract]   [Full Text] [Related]  

  • 3. Flavivirus DNA vaccines--good science, uncertain future.
    Petersen LR; Roehrig JT
    J Infect Dis; 2007 Dec; 196(12):1721-3. PubMed ID: 18190248
    [No Abstract]   [Full Text] [Related]  

  • 4. Evasion of innate and adaptive immunity by flaviviruses.
    Diamond MS
    Immunol Cell Biol; 2003 Jun; 81(3):196-206. PubMed ID: 12752684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serodiagnosis of flaviviral infections and vaccinations in humans.
    Kuno G
    Adv Virus Res; 2003; 61():3-65. PubMed ID: 14714429
    [No Abstract]   [Full Text] [Related]  

  • 6. American Society of Tropical Medicine and Hygiene--55th Annual Meeting. Vaccine development against flaviviruses. 12-16 November 2006, Atlanta, GA, USA.
    Klade C
    IDrugs; 2007 Feb; 10(2):96-8. PubMed ID: 17285458
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunopathology of flavivirus infections.
    King NJ; Getts DR; Getts MT; Rana S; Shrestha B; Kesson AM
    Immunol Cell Biol; 2007 Jan; 85(1):33-42. PubMed ID: 17146465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIAID workshop on Flavivirus immunity.
    Augustine AD; Cassetti MC; Ennis FA; Harris E; Hildebrand WH; Repik PM
    Viral Immunol; 2010 Jun; 23(3):235-40. PubMed ID: 20565288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccines for flaviviruses.
    Putnak R; Porter K; Schmaljohn C
    Adv Virus Res; 2003; 61():445-68. PubMed ID: 14714440
    [No Abstract]   [Full Text] [Related]  

  • 10. Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity.
    VanBlargan LA; Goo L; Pierson TC
    Microbiol Mol Biol Rev; 2016 Dec; 80(4):989-1010. PubMed ID: 27784796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of antibody-mediated neutralization and protection against flavivirus.
    Dai L; Wang Q; Qi J; Shi Y; Yan J; Gao GF
    IUBMB Life; 2016 Oct; 68(10):783-91. PubMed ID: 27604155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Flaviviral Proteins in the Induction of Innate Immunity.
    Cedillo-Barrón L; García-Cordero J; Shrivastava G; Carrillo-Halfon S; León-Juárez M; Bustos Arriaga J; León Valenzuela P; Gutiérrez Castañeda B
    Subcell Biochem; 2018; 88():407-442. PubMed ID: 29900506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis.
    Chong HY; Leow CY; Abdul Majeed AB; Leow CH
    Virus Res; 2019 Dec; 274():197770. PubMed ID: 31626874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety concerns with regard to live attenuated flavivirus vaccines.
    Seligman SJ; Gould EA
    J Infect Dis; 2008 Sep; 198(5):794-5. PubMed ID: 18694340
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines.
    Brandler S; Tangy F
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):271-91. PubMed ID: 17869338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a live attenuated vaccine candidate against duck Tembusu viral disease.
    Li G; Gao X; Xiao Y; Liu S; Peng S; Li X; Shi Y; Zhang Y; Yu L; Wu X; Yan P; Yan L; Teng Q; Tong G; Li Z
    Virology; 2014 Feb; 450-451():233-42. PubMed ID: 24503086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flaviviruses].
    Ishikawa T; Konishi E
    Uirusu; 2011 Dec; 61(2):221-38. PubMed ID: 22916569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane and envelope virus proteins co-expressed as lysosome associated membrane protein (LAMP) fused antigens: a potential tool to develop DNA vaccines against flaviviruses.
    Dhalia R; Maciel M; Cruz FS; Viana IF; Palma ML; August T; Marques ET
    An Acad Bras Cienc; 2009 Dec; 81(4):663-9. PubMed ID: 19893892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traditional and novel approaches to flavivirus vaccines.
    Pugachev KV; Guirakhoo F; Trent DW; Monath TP
    Int J Parasitol; 2003 May; 33(5-6):567-82. PubMed ID: 12782056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seeking
    Dos Santos Franco L; Gushi LT; Luiz WB; Amorim JH
    Front Immunol; 2019; 10():2260. PubMed ID: 31616432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.